Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients
Recruiting now · Not applicable
Conditions studied: Thyroid Cancer
In brief
The goal of this clinical trial is to evaluate the usefulness and effectiveness of a newly developed artificial intelligence (AI) chatbot for health education in thyroid cancer patients during the period around their surgery (the perioperative period). The main questions it aims to answer are: Does the AI chatbot improve patients' readiness for discharge, quality of recovery, and active engagement in their own healthcare compared to traditional education methods? How do patients rate the usability and friendliness of this new AI chatbot system? Researchers will compare a group of patients who receive traditional health education (the control group) with a subsequent group of patients who use the new AI chatbot built on the "Coze" platform (the intervention group) to see if the AI chatbot leads to better recovery experiences and higher patient engagement. Participants will be asked to: Access and interact with the AI chatbot to receive personalized health guidance, ask questions, and get instant feedback during their hospital stay. Complete a set of questionnaires on the morning of their hospital discharge to evaluate their recovery quality, readiness to leave the hospital, and level of engagement in their care. Complete an extra survey regarding the usability and acceptability of the chatbot system (only for participants in the AI chatbot group).
Key facts
- Study ID
- NCT07634978
- Run by
- Tianjin Medical University Cancer Institute and Hospital
- People needed
- 150
- Starts
- 2026-01-01
- Expected to finish
- 2026-08-31
- Last updated by the study team
- 2026-06-09
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with thyroid cancer in accordance with the clinical diagnostic criteria, and confirmed by ultrasonography and histopathological examination.
- Scheduled to undergo elective surgery for thyroid cancer.
- Mentally competent to understand the study protocol, and voluntarily provided written informed consent to participate in this study.
You may not qualify if…
- Aged less than 18 years.
- Concurrently diagnosed with malignant tumors in other organs or severe complications/dysfunctions of other major organs.
- Patients who are anticipated to be unable to complete the study protocol due to plans for hospital/department transfer, or high risk of treatment discontinuation.
Where it is running
- Tianjin Medical University Cancer Institute and Hospital — Tianjin, Tianjin Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.